Market Overview:
The global cholesterol testing services market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of lifestyle diseases, such as obesity and diabetes, which are major risk factors for cardiovascular diseases (CVDs), such as heart attack and stroke. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, accounting for 17 million deaths each year. Furthermore, rising geriatric population is also contributing significantly to the growth of this market. Based on type, the global cholesterol testing services market can be segmented into cholesterol screening and cholesterol lab testing services. Cholesterol screening is a process that helps in identifying people who have high levels of blood cholesterol but do not have any symptoms yet. On the other hand, lab testing services involve analysis of blood samples in a laboratory setting in order to measure various components of lipid profile including total cholesterol level, HDL-C level, LDL-C level and triglycerides levels etc., which help in diagnosing and managing CVDs effectively. Based on application, the global cholesterol testing services market can be segmented into physicians/providers and hospitals; employers; health plans; managed care organizations (MCOs); government agencies; accountable care organizations (ACOs); integrated delivery networks (IDNs) and patients segments respectively.
Product Definition:
Cholesterol testing services are used to measure the amount of cholesterol in a person's blood. This information can be used to help determine a person's risk for heart disease.
Cholesterol Screening:
A cholesterol screening test is used to detect the level of high density lipoprotein (HDL) and low-density lipoprotein (LDL) in the body. High levels of HDL are associated with lower rates of cardiovascular diseases, while elevated levels of LDL are linked with increased risks for heart disease. Hence, cholesterol testing services play an important role in preventive care for cardiac patients as well as healthy individuals across the globe.
Cholesterol Lab Testing Services:
A: cholesterol lab testing services are used for measuring the level of cholesterol in the body. Cholesterol is a type of fat that is found in the blood, tissues, and organs. The normal range for total cholesterol depends on age and gender.
Application Insights:
The physicians/ providers segment dominated the global cholesterol testing services market in 2017. This is attributed to factors such as rising prevalence of high blood cholesterol levels and an increase in the number of cardiovascular diseases (CVDs). According to a study published by NCBI, it was estimated that around 1 out of 3 adults have at least one type of Metabolic Syndrome. Moreover, according to data published by WHO, it was reported that around half of all deaths occur due to CVDs globally. These statistics indicate a significant need for cholesterol testing among population groups across the globe. Thus, contributing towards revenue growth during this forecast period.
The hospitals/ laboratories segment is expected register moderate growth over the forecast period owing to factors such as increasing awareness about early diagnosis and treatment options for various chronic conditions.
Regional Analysis:
North America dominated the global cholesterol testing services market in 2017. This can be attributed to the presence of sophisticated healthcare infrastructure, high awareness levels coupled with a large patient pool seeking for early diagnosis and treatment of diseases. The U.S., which accounted for over 80% share in North America, is one of the most developed countries when it comes to healthcare facilities and services across all age groups and socioeconomic classes.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to improving economic conditions leading to an increase in disposable income along with rising population awareness regarding risk factors associated with cardiovascular diseases such as stroke or heart failure & hypertension among others that affect cholesterol levels are some major factors driving growth over this region.
Growth Factors:
- Increasing incidence of lifestyle diseases such as obesity and diabetes, which are associated with high levels of cholesterol
- Growing awareness about the health risks associated with high cholesterol levels
- Rising demand for preventive healthcare services
- Technological advancements in cholesterol testing methods and devices
- Growing number of private clinics and diagnostic laboratories offering cholesterol testing services
Scope Of The Report
Report Attributes
Report Details
Report Title
Cholesterol Testing Services Market Research Report
By Type
Cholesterol Screening, Cholesterol Lab Testing Services
By Application
Physicians/Providers and Hospitals, Employers, Health Plans, and Managed Care Organizations (MCOs), Government Agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs), Patients
By Companies
Laboratory Corporation of America Holdings (LabCorp) (U.S.), Quest Diagnostics Incorporated (U.S.), Eurofins Scientific (Luxembourg), Spectra Laboratories Inc. (U.S.), Unilabs (Switzerland), SYNLAB International GmbH (Germany), Bio-Reference Laboratories Inc. (U.S.), Clinical Reference Laboratory, Inc. (CRL) (U.S.), ACM Medical Laboratory (U.S.), Adicon Clinical Laboratory (China)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Cholesterol Testing Services Market Report Segments:
The global Cholesterol Testing Services market is segmented on the basis of:
Types
Cholesterol Screening, Cholesterol Lab Testing Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Physicians/Providers and Hospitals, Employers, Health Plans, and Managed Care Organizations (MCOs), Government Agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs), Patients
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Laboratory Corporation of America Holdings (LabCorp) (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Eurofins Scientific (Luxembourg)
- Spectra Laboratories Inc. (U.S.)
- Unilabs (Switzerland)
- SYNLAB International GmbH (Germany)
- Bio-Reference Laboratories Inc. (U.S.)
- Clinical Reference Laboratory, Inc. (CRL) (U.S.)
- ACM Medical Laboratory (U.S.)
- Adicon Clinical Laboratory (China)
Highlights of The Cholesterol Testing Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cholesterol Screening
- Cholesterol Lab Testing Services
- By Application:
- Physicians/Providers and Hospitals
- Employers, Health Plans, and Managed Care Organizations (MCOs)
- Government Agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs)
- Patients
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cholesterol Testing Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cholesterol testing services are a way to measure the amount of cholesterol in your blood. This can help you learn if you have high cholesterol, and if so, what steps you can take to lower it.
Some of the key players operating in the cholesterol testing services market are Laboratory Corporation of America Holdings (LabCorp) (U.S.), Quest Diagnostics Incorporated (U.S.), Eurofins Scientific (Luxembourg), Spectra Laboratories Inc. (U.S.), Unilabs (Switzerland), SYNLAB International GmbH (Germany), Bio-Reference Laboratories Inc. (U.S.), Clinical Reference Laboratory, Inc. (CRL) (U.S.), ACM Medical Laboratory (U.S.), Adicon Clinical Laboratory (China).
The cholesterol testing services market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cholesterol Testing Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cholesterol Testing Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cholesterol Testing Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cholesterol Testing Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cholesterol Testing Services Market Size & Forecast, 2020-2028
4.5.1 Cholesterol Testing Services Market Size and Y-o-Y Growth
4.5.2 Cholesterol Testing Services Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cholesterol Screening
5.2.2 Cholesterol Lab Testing Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Physicians/Providers and Hospitals
6.2.2 Employers
6.2.3 Health Plans
6.2.4 and Managed Care Organizations (MCOs)
6.2.5 Government Agencies
6.2.6 Accountable Care Organizations (ACOs)
6.2.7 and Integrated Delivery Networks (IDNs)
6.2.8 Patients
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cholesterol Testing Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cholesterol Testing Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cholesterol Screening
9.6.2 Cholesterol Lab Testing Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Physicians/Providers and Hospitals
9.10.2 Employers
9.10.3 Health Plans
9.10.4 and Managed Care Organizations (MCOs)
9.10.5 Government Agencies
9.10.6 Accountable Care Organizations (ACOs)
9.10.7 and Integrated Delivery Networks (IDNs)
9.10.8 Patients
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cholesterol Screening
10.6.2 Cholesterol Lab Testing Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Physicians/Providers and Hospitals
10.10.2 Employers
10.10.3 Health Plans
10.10.4 and Managed Care Organizations (MCOs)
10.10.5 Government Agencies
10.10.6 Accountable Care Organizations (ACOs)
10.10.7 and Integrated Delivery Networks (IDNs)
10.10.8 Patients
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cholesterol Screening
11.6.2 Cholesterol Lab Testing Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Physicians/Providers and Hospitals
11.10.2 Employers
11.10.3 Health Plans
11.10.4 and Managed Care Organizations (MCOs)
11.10.5 Government Agencies
11.10.6 Accountable Care Organizations (ACOs)
11.10.7 and Integrated Delivery Networks (IDNs)
11.10.8 Patients
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cholesterol Screening
12.6.2 Cholesterol Lab Testing Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Physicians/Providers and Hospitals
12.10.2 Employers
12.10.3 Health Plans
12.10.4 and Managed Care Organizations (MCOs)
12.10.5 Government Agencies
12.10.6 Accountable Care Organizations (ACOs)
12.10.7 and Integrated Delivery Networks (IDNs)
12.10.8 Patients
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cholesterol Screening
13.6.2 Cholesterol Lab Testing Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Physicians/Providers and Hospitals
13.10.2 Employers
13.10.3 Health Plans
13.10.4 and Managed Care Organizations (MCOs)
13.10.5 Government Agencies
13.10.6 Accountable Care Organizations (ACOs)
13.10.7 and Integrated Delivery Networks (IDNs)
13.10.8 Patients
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cholesterol Testing Services Market: Competitive Dashboard
14.2 Global Cholesterol Testing Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Laboratory Corporation of America Holdings (LabCorp) (U.S.)
14.3.2 Quest Diagnostics Incorporated (U.S.)
14.3.3 Eurofins Scientific (Luxembourg)
14.3.4 Spectra Laboratories Inc. (U.S.)
14.3.5 Unilabs (Switzerland)
14.3.6 SYNLAB International GmbH (Germany)
14.3.7 Bio-Reference Laboratories Inc. (U.S.)
14.3.8 Clinical Reference Laboratory, Inc. (CRL) (U.S.)
14.3.9 ACM Medical Laboratory (U.S.)
14.3.10 Adicon Clinical Laboratory (China)
